Dasatinib-related effusion lymphoma in a patient treated for chronic myeloid leukaemia

被引：8
|
作者：
Miyagi, Daichi [1 ]
Chen, Wei-Yu [2 ]
Chen, Bo-Jung [3 ]
Su, Ying-Zhen [4 ]
Kuo, Chun-Chi [4 ]
Karube, Kennosuke [5 ]
Chuang, Shih-Sung [4 ,6 ]
机构：
[1] Univ Ryukyus, Fac Med, Sch Med, Nishihara, Okinawa, Japan
[2] Chi Mei Med Ctr, Dept Med, Div Hematooncol, Tainan, Taiwan
[3] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, New Taipei, Taiwan
[4] Chi Mei Med Ctr, Dept Pathol, 901 Chung Hwa Rd, Tainan 71004, Taiwan
[5] Univ Ryukyus, Grad Sch Med, Dept Pathol & Cell Biol, Nishihara, Okinawa, Japan
[6] Natl Taiwan Univ, Sch Med, Dept Pathol, Taipei, Taiwan
来源：
CYTOPATHOLOGY | 2020年 / 31卷 / 06期
关键词：
chronic myeloid leukaemia; clonal lymphoproliferation; dasatinib; effusion lymphoma; primary effusion lymphoma; tyrosine kinase inhibitor; PLEURAL EFFUSION; IMATINIB;
D O I：
10.1111/cyt.12890
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
This report presents the clinical, cytological and molecular features of pleural effusion lymphoma which developed in a patient treated for chronic myeloid leukaemia after five years of dasatinib therapy. The effusion lymphoma recurred three times but largely resolved after pleurocentesis and steroid treatment. More reports on such unusual cases may improve our understanding and management of patients with this rare adverse effect associated with dasatinib.
引用
收藏
页码：602 / 606
页数：5
相关论文
共 50 条
  • [1] Recurrence of pleural effusion on bosutinib therapy in a dasatinib treated patient with chronic myeloid leukaemia
    Milojkovic, D.
    Zaiga-Castleton, A.
    Marin, D.
    Reid, A.
    Foroni, L.
    Rezvani, K.
    Bua, M.
    Khorashad, J.
    Goldman, J.
    Apperley, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 83 - 83
  • [2] Spontaneous regression of dasatinib-related primary effusion lymphoma-like lymphoma
    Kenta Hayashino
    Yusuke Meguri
    Ryouya Yukawa
    Aya Komura
    Makoto Nakamura
    Chikamasa Yoshida
    Kazuhiko Yamamoto
    Wakako Oda
    Kenji Imajo
    International Journal of Hematology, 2023, 117 : 137 - 142
  • [3] Spontaneous regression of dasatinib-related primary effusion lymphoma-like lymphoma
    Hayashino, Kenta
    Meguri, Yusuke
    Yukawa, Ryouya
    Komura, Aya
    Nakamura, Makoto
    Yoshida, Chikamasa
    Yamamoto, Kazuhiko
    Oda, Wakako
    Imajo, Kenji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (01) : 137 - 142
  • [4] Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib
    SahBandar, Ivo N.
    Sy, Chandler B.
    van den Akker, Tayler
    Kim, David
    Geyer, Julia T.
    Chadburn, Amy
    Cesarman, Ethel
    Inghirami, Giorgio
    Allan, John
    Siddiqui, Momin T.
    Ouseph, Madhu M.
    PATHOBIOLOGY, 2023, 90 (05) : 356 - 363
  • [5] Dasatinib-related left ventricular dysfunction in a patient with chronic myelogenous leukemia
    Kawanami, Yuka
    Yamaguchi, Kazuto
    Yamasaki, Seita
    Kagawa, Yuzo
    Sato, Hirotomo
    Watanabe, Nobuhide
    Endo, Akihiro
    Yoshitomi, Hiroyuki
    Tanabe, Kazuaki
    JOURNAL OF ECHOCARDIOGRAPHY, 2024, 22 (02) : 99 - 101
  • [6] Dasatinib-induced panniculitis in a patient with chronic myeloid leukaemia
    Nagasawa, Yusuke
    Iinuma, Shin
    Fujii, Mizue
    Kanno, Kyoko
    Honma, Masaru
    Yuzawa, Sayaka
    Ishida-Yamamoto, Akemi
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (01) : 87 - 88
  • [7] Dasatinib-induced panniculitis in a patient with chronic myeloid leukaemia
    Yusuke Nagasawa
    Shin Iinuma
    Mizue Fujii
    Kyoko Kanno
    Masaru Honma
    Sayaka Yuzawa
    Akemi Ishida-Yamamoto
    European Journal of Dermatology, 2021, 31 : 87 - 88
  • [8] Dasatinib causing Intracerebral Bleeding in a Patient with Chronic Myeloid Leukaemia
    Rathod, Santosh Govind
    Khan, Afaq Ahmad
    Geelani, Sajad Ahmed
    Roshan, Reshma
    Bhat, Javid Rasool
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (06)
  • [9] Dasatinib-induced colitis in a patient with chronic myeloid leukaemia
    Gluch, Alexander Edmund
    Subhaharan, Deloshaan
    Pillai, Sooraj
    Ramaswamy, Pradeep Kakkadasam
    BMJ CASE REPORTS, 2025, 18 (01)
  • [10] Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event
    Pasquale, Raffaella
    Bucelli, Cristina
    Bellani, Valentina
    Zappa, Manuela
    Iurlo, Alessandra
    Cattaneo, Daniele
    FRONTIERS IN ONCOLOGY, 2022, 12
12345